CD19 and acute myeloid leukemia: These non-gated CD93 CAR T cells also expressed a second inhibitory CD19 CAR (iCAR), which was chosen for this investigation because it selectively targeted CD19, an antigen that is present on healthy cells but absent from AML cells.